Brian in China - Ataxia Stem Cell Patient

Brian traveled to China over the summer of 2008 to receive a second round of adult stem cell therapy for the treatment of symptoms associated with Ataxia. A muscle wasting neurological disorder, Brian's SCA1 saw marked improvement a second time around. Adult stem cells are not a cure - but may offer quality-of-life improvements to patients with few or no alternatives. Hospitals in China now treat a wide range of spinal cord injuries, neurodegenerative conditions and are rapidly tackling cardiovascular conditions as well. While we have hope that adult stem cell therapies will be available in many other countries in the near future, many conditions are currently treated through providers in China.

Improvement statistics

Based on follow-up reports from 143 patients across 415 forms, here is the percentage who self-reported any improvement after treatment.

83%
Speech (babbling for infants)
reported improvement · N=114
83%
Drooling
reported improvement · N=54
83%
Swallowing
reported improvement · N=101
79%
Fine hand movements
reported improvement · N=129
78%
Memory
reported improvement · N=60
77%
Muscle stiffness
reported improvement · N=102
76%
Coordination
reported improvement · N=129
76%
Weight loss
reported improvement · N=86
75%
Control of movement
reported improvement · N=126
75%
Tremors
reported improvement · N=90

About this data

Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.

Internationally accredited

Held to global laboratory and biologics standards.